UPDATE: 3 December: The Department of Health review team is seeking views from individuals and organisations that engage with NICE or have a wider interest in its operations. These stakeholders include, but are not limited to, individuals, commissioners, practitioners, pharmaceutical industry, civil society groups, and other health and care institutions. The call for evidence will run from 1st December 2014 to 2nd January 2015. More information on how to submit evidence is available here.
All non-departmental public bodies (NDPBs) undergo a review at least once every 3 years. NICE’s review will begin this month, with a final report scheduled to be published in February 2015.
The triennial reviews aim to challenge the continuing need for individual NDPBs, both their function and their form, and review the control and governance arrangements.
The first stage of NICE’s review will examine the continuing need for us, and whether our form, including operating at arm’s length from government, remains appropriate. This will be answered by ministers. Given that NICE was established in primary legislation in 2012, we are expecting a positive conclusion to this first stage.
If the outcome of this is that delivery should continue, the second stage of the review will assess whether NICE is operating efficiently and in line with the recognised principles of good corporate governance. Does NICE’s work fit well within the wider health and care system and current Government policy. And if so, are the powers delegated to us sufficient to allow us to operate effectively? A consultation period will take place on this second stage, with external stakeholders being asked their views.
NICE will be closely involved in the review process, which will include the opportunity to see a draft report before it is published.
More information will be available on the website as the review progresses